|
|
|
|
LEADER |
01323 am a22002893u 4500 |
001 |
96529 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Buganim, Yosef
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Biology
|e contributor
|
100 |
1 |
0 |
|a Whitehead Institute for Biomedical Research
|e contributor
|
100 |
1 |
0 |
|a Buganim, Yosef
|e contributor
|
100 |
1 |
0 |
|a Faddah, Dina A.
|e contributor
|
100 |
1 |
0 |
|a Jaenisch, Rudolf
|e contributor
|
700 |
1 |
0 |
|a Faddah, Dina A.
|e author
|
700 |
1 |
0 |
|a Jaenisch, Rudolf
|e author
|
245 |
0 |
0 |
|a Mechanisms and models of somatic cell reprogramming
|
260 |
|
|
|b Nature Publishing Group,
|c 2015-04-13T14:56:20Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/96529
|
520 |
|
|
|a Whitehead Institute for Biomedical Research (Jerome and Florence Brill Graduate Student Fellowship)
|
520 |
|
|
|a National Institutes of Health (U.S.) (US NIH grant RO1-CA087869)
|
520 |
|
|
|a National Institutes of Health (U.S.) (US NIH grant R37-CA084198)
|
520 |
|
|
|a National Science Foundation (U.S.) (NSF Graduate Research Fellowship)
|
520 |
|
|
|a National Institutes of Health (U.S.) ((NIH) Kirschstein National Research Service Award,1 F32 GM099153-01A1)
|
520 |
|
|
|a Vertex Pharmaceuticals Incorporated (Vertex Scholar)
|
546 |
|
|
|a en_US
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Nature Reviews Genetics
|